Brief: Xeris Biopharma Announces Private Exchange Of Convertible Notes
11/06/2026 12:05
BRIEF-Xeris Biopharma Announces Private Exchange Of Convertible Notes June 11 (Reuters) - Xeris Biopharma Holdings Inc XERS.O:
XERIS BIOPHARMA ANNOUNCES PRIVATE EXCHANGE OF CONVERTIBLE NOTES
XERIS BIOPHARMA - TO RETIRE $23 MILLION PRINCIPAL OF NOTES FOR $23 MILLION CASH AND SHARES
Source text: ID:nBw4gglnva
Further company coverage: XERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest